ArticleActa oncologica (Stockholm, Sweden)2024
The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy - the TABANETOC trial: study protocol for a randomized clinical multicenter trial.
Anna Karlsson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.